Review - Helicobacter, inflammation, immunology and vaccines.
Helicobacter pylori
adaptive immunity
cytokines
inflammation
innate immunity
vaccines
Journal
Helicobacter
ISSN: 1523-5378
Titre abrégé: Helicobacter
Pays: England
ID NLM: 9605411
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
entrez:
12
9
2020
pubmed:
13
9
2020
medline:
2
7
2021
Statut:
ppublish
Résumé
Understanding the mechanisms involved in induction and regulation of the immune and inflammatory response to Helicobacter pylori is extremely important in determining disease outcomes. H pylori expresses a plethora of factors that influence the host response. Vaccines against H pylori are desperately needed for the prevention of gastric carcinogenesis, especially with the increasing trends in antimicrobial resistance. This review summarizes some important findings, published between 1 April 2019 and 31 March 2020, in the areas of H pylori-mediated inflammation, immunity and vaccines.
Substances chimiques
Bacterial Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12737Subventions
Organisme : Medical Research Council
ID : G0601170
Pays : United Kingdom
Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Uotani T, Murakami K, Uchida T, et al. Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection. Helicobacter. 2019;24(3):e12583.
Semper RP, Vieth M, Gerhard M, Mejias-Luque R Helicobacter pylori exploits the NLRC4 inflammasome to dampen host defenses. J Immunol. 2019;203(8):2183-2193.
Balic JJ, Saad MI, Dawson R, et al. Constitutive STAT3 serine phosphorylation promotes Helicobacter-mediated gastric disease. Am J Pathol. 2020;190(6):1256-1270.
Mejías-Luque R, Lozano-Pope I, Wanisch A, et al. Increased LIGHT expression and activation of non-canonical NF-κB are observed in gastric lesions of MyD88-deficient mice upon Helicobacter felis infection. Sci Rep. 2019;9(1):7030.
Dang Y, Zhang Y, Xu L, et al. PUMA-mediated epithelial cell apoptosis promotes Helicobacter pylori infection-mediated gastritis. Cell Death Dis. 2020;11(2):139.
Kong H, You N, Chen H, et al. Helicobacter pylori-induced adrenomedullin modulates IFN-gamma-producing T-cell responses and contributes to gastritis. Cell Death Dis. 2020;11(3):189.
Lv YP, Cheng P, Zhang JY, et al. Helicobacter pylori-induced matrix metallopeptidase-10 promotes gastric bacterial colonization and gastritis. Sci Adv. 2019;5(4):eaau6547.
Kuo CJ, Chen CY, Lo HR, et al. Helicobacter pylori induces IL-33 production and recruits ST-2 to lipid rafts to exacerbate inflammation. Cells. 2019;8(10).
El-Zaatari M, Bishu S, Zhang M, et al. Aim2-mediated/IFN-beta-independent regulation of gastric metaplastic lesions via CD8+ T cells. JCI. Insight. 2020;5(5):1290.
Shamsdin SA, Alborzi A, Ghaderi A, Lankrani KB, Pouladfar GR. Significance of TC9 and TH9 in Helicobacter pylori-induced gastritis. Helicobacter. 2020;25(1):e12672.
Bagheri N, Shirzad H, Mirzaei Y, et al. T-bet(+) cells polarization in patients infected with Helicobacter pylori increase the risk of peptic ulcer development. Arch Med Res. 2019;50(3):113-121.
Sanaii A, Shirzad H, Haghighian M, et al. Role of Th22 cells in Helicobacter pylori-related gastritis and peptic ulcer diseases. Mol Biol Rep. 2019;46(6):5703-5712.
Capitani N, Codolo G, Vallese F, et al. The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling. Cell Microbiol. 2019;21(5):e13006.
Yasmin S, Dixon B, Olivares-Villagomez D, Algood HMS. Interleukin-21 (IL-21) downregulates dendritic cell cytokine responses to Helicobacter pylori and modulates T lymphocyte IL-17A expression in Peyer's patches during infection. Infect Immun. 2019;87(11):e00237-19.
Bostick JW, Wang Y, Shen Z, et al. Dichotomous regulation of group 3 innate lymphoid cells by nongastric Helicobacter species. Proc Natl Acad Sci USA. 2019;116(49):24760-24769.
Chu TH, Huang ST, Yang SF, et al. Hepatoma-derived growth factor participates in Helicobacter pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis. Oncogene. 2019;38(37):6461-6477.
Yang XT, Wang ZJ. CD177 expression and inflammation grade in Helicobacter pylori-infected wild-type and CD177(-/-) C57BL/6 mice. Anal Cell Pathol (Amst). 2019;2019:9506863.
Gobert AP, Latour YL, Asim M, et al. Bacterial pathogens hijack the innate immune response by activation of the reverse transsulfuration pathway. MBio. 2019;10(5):e02174-19.
Pachathundikandi SK, Blaser N, Bruns H, Backert S. Helicobacter pylori avoids the critical activation of NLRP3 inflammasome-mediated production of oncogenic mature IL-1beta in human immune cells. Cancers (Basel). 2020;12(4):803.
Chonwerawong M, Ferrand J, Chaudhry HM, et al. Innate immune molecule NLRC5 protects mice from Helicobacter-induced formation of gastric lymphoid tissue. Gastroenterology. 2020;159(1):169-182.e8.
Zhao Y, Lu F, Ye J, et al. Myeloid-derived suppressor cells and gammadeltaT17 cells contribute to the development of gastric MALT lymphoma in H felis-infected mice. Front Immunol. 2019;10:3104.
Ding L, Li Q, Chakrabarti J, et al. MiR130b from Schlafen4(+) MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer. Gut. 2020. https://doi.org/10.1136/gutjnl-2019-318817
Codolo G, Toffoletto M, Chemello F, et al. Helicobacter pylori dampens HLA-II expression on macrophages via the up-regulation of miRNAs targeting CIITA. Front Immunol. 2019;10:2923.
Arnold IC, Zhang X, Artola-Boran M, et al. BATF3-dependent dendritic cells drive both effector and regulatory T-cell responses in bacterially infected tissues. PLoS Pathog. 2019;15(6):e1007866.
Mirzaei N, Poursina F, Moghim S, Rashidi N, Ghasemian SH. The study of H pylori putative candidate factors for single- and multi-component vaccine development. Crit Rev Microbiol. 2017;43(5):631-650.
Liu M, Zhong Y, Chen J, et al. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection. Vaccine. 2020;38(14):3031-3041.
Guo L, Hong D, Wang S, et al. Therapeutic protection against H pylori infection in Mongolian gerbils by oral immunization with a tetravalent epitope-based vaccine with polysaccharide adjuvant. Front Immunol. 2019;10:1185.
Hornburg D, Kruse T, Anderl F, et al. A mass spectrometry guided approach for the identification of novel vaccine candidates in Gram-negative pathogens. Sci Rep. 2019;9(1):17401.
Liu Q, Li X, Zhang Y, et al. Orally-administered outer-membrane vesicles from Helicobacter pylori reduce H pylori infection via Th2-biased immune responses in mice. Pathog Dis. 2019;77(5).
Xue RY, Guo MF, Guo L, et al. Synthetic lipopeptide enhances protective immunity against Helicobacter pylori infection. Front Immunol. 2019;10:1372.
Espinosa-Ramos D, Caballero-Hernandez D, Gomez-Flores R, et al. Immunization with a synthetic Helicobacter pylori peptide induces secretory IgA antibodies and protects mice against infection. Can J Infect Dis Med Microbiol. 2019;2019:e8595487.
Ashrafi H, Siraji MI, Showva NN, et al. Structure to function analysis with antigenic characterization of a hypothetical protein, HPAG1_0576 from Helicobacter pylori HPAG1. Bioinformation. 2019;15(7):456-466.
Cho SY, Song WS, Oh HB, Kim HU, Jung HS, Yoon SI. Structural analysis of the flagellar capping protein FliD from Helicobacter pylori. Biochem Biophys Res Commun. 2019;514(1):98-104.
Khan M, Khan S, Ali A, et al. Immunoinformatics approaches to explore Helicobacter pylori proteome (virulence factors) to design B and T cell multi-epitope subunit vaccine. Sci Rep. 2019;9(1):13321.
Urrutia-Baca VH, Gomez-Flores R, De La Garza-Ramos MA, Tamez-Guerra P, Lucio-Sauceda DG, Rodriguez-Padilla MC. Immunoinformatics approach to design a novel epitope-based oral vaccine against Helicobacter pylori. J Comput Biol. 2019;26(10):1177-1190.
Pasala C, Chilamakuri CSR, Katari SK, Nalamolu RM, Bitla AR, Amineni U. Epitope-driven common subunit vaccine design against H pylori strains. J Biomol Struct Dyn. 2019;37(14):3740-3750.
Aliramaei MR, Khorasgani MR, Rahmani MR, Zarkesh Esfahani SH, Emamzadeh R. Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice. Microb Pathog. 2019;142:e103926.
Sun N, Zhang R, Duan G, et al. A food-grade engineered Lactococcus lactis strain delivering Helicobacter pylori Lpp20 alleviates bacterial infection in H pylori-challenged mice. Biotechnol Lett. 2019;41(12):1415-1421.
Longet S, Abautret-Daly A, Davitt CJH, et al. An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses. NPJ Vaccines. 2019;4:45.
Nemattalab M, Shenagari M, Taheri M, et al. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice. Cytokine. 2020;126:e154866.
Xu N, Ruan G, Liu W, et al. Vaccine-induced gastric CD4(+) tissue-resident memory T cells proliferate in situ to amplify immune response against Helicobacter pylori insult. Helicobacter. 2019;24(5):e12652.
Akter S, Jeverstam F, Lundgren A, et al. The frequency of circulating integrin alpha4beta7(+) cells correlates with protection against Helicobacter pylori infection in immunized mice. Helicobacter. 2019;24(6):e12658.
Sutton P, Boag JM. Status of vaccine research and development for Helicobacter pylori. Vaccine. 2019;37(50):7295-7299.